文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 基础医学 > 2014 Crosstalk between ERK, AKT, and cell survival
侵权投诉

2014 Crosstalk between ERK, AKT, and cell survival

Crosstalk between ERK, AKT, and cell survival

Paul Dent

Department of Biochemistry; Massey Cancer Center; Virginia Commonwealth University; Richmond, VA USA

Keywords: K-RAS, NSCLC, HNSCC, EGFR, PI3K/Akt, MAPK/ERK, erlotinib, PI-103Submitted: 12/13/2013Accepted: 12/13/2013

doc.guandang.net

Correspondence to: Paul Dent; Email: pdent@vcu.edu

Commentary to: Toulany M, Minjgee M, Saki M, Holler M, Meier F, Eicheler W, Rodemann HP. ERK2-dependent reactivation of Akt mediates the limited response of tumor cells with constitu-tive K-RAS activity to PI3K inhibition. Cancer Biol Ther 2014; 5:317-28; PMID:24351425; doc.guandang.net

doc.guandang.net I

t is historically well nown that signaling by the PI3K-AKT and MEK1/2-ERK1/2 pathways in a cell type-dependent fashion can collaborate to maintain cell viability.1-3 Signaling pathways can also crosstalk with each other wherein one pathway can signal to either enhance or suppress signaling by another.4 Signaling by the ERK1/2 path-way can also stimulate release of growth factors which can feed back onto tumor cells to re-energize signaling pathways.5 The studies described by Toulany et al. add to this knowledge base by examining the relationship between PI3K-AKT and MEK1/2-ERK1/2 pathway signaling, EGF receptor signaling, K-RAS func-tion, and tumor cell survival.6

Initial studies comparing lung and head and neck tumor cells demonstrated that the total level of K-RAS activity in tumor cells rather than its mutational status correlated with clonogenic plat-ing efficiency/survival. Studies using the EGF receptor inhibitor erlotinib dem-onstrated in head and neck tumor cells with elevated EGF receptor expression that they used this receptor to cause high levels of wild-type K-RAS activity and

thus colony plating efficiency; in cells expressing a mutant activated K-RAS or with low EGF receptor expression inhibi-tors of the EGF receptor had no effect

on plating efficiency. Downstream of

K-RAS the PI3K/mTOR pathway was judged to play a greater role than the

ERK1/2 pathway in regulating colony

formation, though in cells expressing mutant active K-RAS the ability of a PI3K/mTOR inhibitor to cause a sus-tained ~24 h reduction in phospho-AKT levels was not complete.

Cancer Biology & Therapy 245

2014 Crosstalk between ERK, AKT, and cell survival

Based on the possibility that crosstalk could be occurring between the PI3K and ERK1/2 pathways, the authors then examined at later time points (24 h) the role of ERK1/2 in mediating sustained AKT phosphorylation in the face of a PI3K/mTOR inhibitor. Inhibition of MEK1/2 or knockdown of ERK2 blocked sustained AKT activity in cells treated with a PI3K/mTOR inhibitor. In colony formation assays inhibition of MEK1/2 synergized with inhibition of PI3K/mTOR signaling to kill tumor cells. Thus in cells with constitutive K-RAS activ-ity, short-term inhibition of PI3K/mTOR suppresses AKT activity that rebounds by 24 h; the rebound being due to ERK1/2 pathway signaling.

The present studies do not further explore how/why this form of crosstalk signaling occurs, though enhanced para-crine ligand signaling through the EGF receptor was ruled out. It is possible that modulation of PTEN function by MEK1 activity or signaling by H-RAS (that pref-erentially binds PI3K) may play roles in this process.7 Further studies will thus be required to define this new pathway by which ERK regulates AKT.

Disclosure of Potential Conflicts of InterestNo potential conflicts of interest were disclosed.AcknowledgmentsP Dent is funded by R01 DK52825.References1. Jarvis WD, Fornari FA Jr., Auer KL, Freemerman AJ,

Szabo E, Birrer MJ, Johnson CR, Barbour SE, Dent

P, Grant S. Coordinate regulation of stress- and mito-gen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol Pharmacol 1997; 52:935-47; PMID:9415703

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email